Aeglea Bio Therapeutics Inc (NASDAQ:AGLE)
| 1.58 Delayed Data As of May 27 |  +0.03 / +1.94%Today’s Change | 1.29 Today|||52-Week Range 8.50 | -66.74% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 6.1M | 4.6M | 5.2M | 3.9M | |
| Depreciation And Amortization | 89.0K | 132.0K | 249.0K | 293.0K | ||
| Operating Expenses | Gross Income | 6.0M | -- | -- | -- | |
| General Expenses | 17.3M | 26.4M | 32.6M | 49.1M | ||
| Research And Development | 11.5M | 18.1M | 22.8M | 36.7M | ||
| Total Operating Expenses | 17.4M | 26.5M | 32.9M | 49.4M | ||
| Non-Operating Expenses | Operating Income | -11.3M | -21.9M | -27.7M | -45.5M | |
| Other Expenses | -2.0K | -36.0K | -42.0K | -57.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -11.3M | -21.7M | -27.2M | -44.3M | |
| Preferred Dividend | -228.0K | 0.00 | 0.00 | 0.00 | ||
| Net Income | -11.3M | -21.7M | -27.2M | -44.3M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 13.7M | 9.8M | 15.1M | 20.8M | |
| Shares To Calculate EPS Diluted | 13.7M | 9.8M | 15.1M | 20.8M | ||
| Earnings Per Share | EPS | -$0.84 | -$2.22 | -$1.80 | -$2.13 | |
| EPS Diluted | -$0.84 | -$2.22 | -$1.80 | -$2.13 | ||
